BELLICUM PHARMACEUTICALS, INC (BLCM) has 40 open-market insider trades by 10 insiders since 2016. The most active filer is David M. Spencer, CTO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Baker Bros. Advisors (GP) LLC via Felix Baker | 10% Owner | — | 1 | $14.3M | 2023-11-22 |
| Kevin M. Slawin | Dir | — | 9 | $5.4M | 2017-02-07 |
| Annemarie Moseley | COOVP | — | 5 | $2.5M | 2016-12-01 |
| BAKER Bros. Advisors L.P. via Julian Baker | 10% Owner | — | 1 | $2.0M | 2017-03-24 |
| David M. Spencer | CTO | — | 10 | $1.5M | 2019-01-03 |
| Ken Moseley | CLOVP | — | 6 | $901K | 2018-01-03 |
| Alan A. Musso | CFOTreasurer | — | 3 | $874K | 2018-05-25 |
| Richard A. Fair | CEOPres | — | 3 | $90K | 2020-03-17 |
| Jon P. Stonehouse | Dir | — | 1 | $46K | 2023-01-03 |
| Shane Ward | Sr VP and Chief Legal SO | — | 1 | $10K | 2020-05-29 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Richard A. Fair | President | Buy | $20K | 2020-03-17 |
| Richard A. Fair | CEO & President | Buy | $50K | 2019-09-10 |
| Shane Ward | Sr. VP and General Counsel | Buy | $10K | 2019-08-29 |
| Richard A. Fair | President | Buy | $20K | 2019-08-21 |
| Jon P. Stonehouse | Director | Buy | $46K | 2018-11-09 |
| David M. Spencer | CTO | Sell | $70K |
Companies that share insiders with BLCM, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2018-09-04 |
| David M. Spencer | CTO | Sell | $305K | 2018-07-18 |
| Alan A. Musso | Treasurer | Sell | $49K | 2018-05-25 |
| Baker Bros. Advisors (GP) LLC | 10% Owner | Sell | $14.3M | 2018-01-17 |
| Alan K. Smith | EVP & Technical Operations | Sell | $5K | 2018-01-09 |
| Alan A. Musso | CFO & Treasurer | Sell | $319K | 2017-12-11 |
| Alan A. Musso | Treasurer | Sell | $61K | 2017-11-27 |
| Alan K. Smith | EVP & Technical Operations | Sell | $5K | 2017-07-24 |
| Ken Moseley | CLO & VP | Sell | $339K | 2017-07-13 |
| David M. Spencer | CSO | Sell | $231K | 2017-07-10 |